PublishedMarch 15, 2023 Category Partner News ReCode Therapeutics Announces First Participants Dosed in a Phase 1 Healthy Volunteer Clinical Trial of Novel Disease-Modifying Genetic Medicine, RCT1100 for the Treatment of Primary Ciliary Dyskinesia
PublishedJanuary 9, 2023 Category Partner News Spexis reports solid safety and pharmacokinetics results from first-in-human study with inhaled murepavadin, a novel macrocycle compound
PublishedNovember 2, 2022 Category Partner News First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE
PublishedAugust 25, 2022 Category Partner News Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
PublishedAugust 3, 2022 Category Partner News Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program